Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR2 | O43614 | 3/20 | 0.43 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.41 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.41 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.41 |
| ▸ | PDPK1 | O15530 | 11/20 | 0.40 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16612825 | 0.94 | HCRTR2 (0.41) | HCRTR2ADRA1DADRA1AADRA1BPDPK1 | |
| SCHEMBL16612742 | 0.87 | HCRTR2 (0.39) | HCRTR2ADRA1DADRA1AADRA1B | |
| SCHEMBL12479162 | 0.81 | HCRTR2 (0.39) | HCRTR2 | |
| SCHEMBL16612726 | 0.75 | ALDH1A1 (0.40) | HCRTR2 | |
| SCHEMBL16612866 | 0.75 | HCRTR2 (0.41) | HCRTR2 | |
| SCHEMBL16612872 | 0.74 | HCRTR2 (0.41) | HCRTR2ADRA1DADRA1AADRA1B | |
| SCHEMBL16612865 | 0.73 | HCRTR2 (0.38) | HCRTR2 | |
| SCHEMBL16612711 | 0.73 | POLB (0.36) | HCRTR2 | |
| SCHEMBL12479497 | 0.72 | HCRTR2 (0.50) | HCRTR2PDPK1HRH4 | |
| SCHEMBL16612778 | 0.71 | HCRTR2 (0.40) | HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2675801-B1 | NOVEL PYRAZOLE AND IMIDAZOLE DERIVATIVES USEFUL AS OREXIN ANTAGONISTS | ACTELION PHARMACEUTICALS LTD (CH) | 2015-04-08 | — | — | EP | claimed |